Actively Recruiting
Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
Led by Yicheng Ma · Updated on 2025-04-11
100
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Autologous epidermal cell transplantation is based on the principle and technology of skin tissue engineering, and is performed by cutting small pieces of autologous skin from patients, isolating and culturing and expanding them, and then transplanting them to the patient's wounds to repair the damage.
CONDITIONS
Official Title
Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a body surface trauma of 30% TBSA or more and a wound that requires at least 2 weeks to repair as assessed by the clinician
You will not qualify if you...
- Patient body surface trauma area less than 30% TBSA
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yicheng Ma
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
Y
Yicheng Ma
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here